Form D · Biotechnology

Microbix Biosystems Inc.

Mississauga, A6 · CIK 0001472866

Offering snapshot reported Jul 21, 2021 · SEC filing

Reported sold
Yet to sell
Offering amount: $43.3K
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 21, 2021InitialYet to sellNo comparisonNot reportedSEC filing
Jun 15, 2018Initial$75,000No comparison4SEC filing
Aug 18, 2011Amendment$248,010$8,899vs May 2, 20112SEC filing
May 2, 2011Initial$239,111No comparison1SEC filing
Mar 29, 2010Initial$296,283No comparison1SEC filing
Sep 23, 2009Initial$88,124No comparison3SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-407162

Source: Form D, filed Jul 21, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Blecher Director
Philip Casselli Executive
Mark Cochran Director
Jim Currie Executive
Vaughn Embro Pantalony Director
William J. Gastle Director, Executive
Anthony Giovinazzo Director
Cameron Groome Director, Executive
James A Long Executive
Martin Marino Director
Andrew C Pollock Director
Joseph Renner Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
265 Watline Avenue
Mississauga, A6, L4Z 1P3